Veradigm | MDRX - Current Liabilities


Veradigm reported $253.09M in Current Liabilities for its fiscal quarter ending in September of 2022.





Current Liabilities Change Date
Alcidion AUD 20.86M 373K Jun/2025
Ambu A/S DKK 1.07B 94M Dec/2025
Amplifon EUR 725.71M 389.21M Sep/2025
Cardinal Health USD 43.31B 3.05B Dec/2025
Centene USD 36.7B 3.93B Dec/2025
Charles River Laboratories USD 1.12B 1.57M Dec/2025
Cigna USD 56.34B 111M Dec/2025
Computer Programs Systems USD 53.75M 3.57M Sep/2025
Convatec Group USD 512.3M 130.7M Dec/2024
CVS Health USD 88.69B 4B Dec/2025
Diasorin EUR 555.45M 289.08M Jun/2025
Elevance Health USD 41.04B 157M Dec/2025
General Electric Aerospace USD 38.98B 1.78B Dec/2025
Gulf Medical Proj AED 171.09M 15.05M Dec/2025
Humana USD 16.35B 166M Dec/2025
IQVIA Holdings USD 8.34B 170M Dec/2025
Laboratory Of America USD 2.82B 194.3M Dec/2025
Maximus USD 608.05M 157.12M Dec/2025
McKesson USD 68.13B 100M Dec/2025
Med Life RON 862.79M 12.64M Sep/2025
Molina Healthcare USD 7.37B 109M Dec/2025
Omnicell USD 476.61M 20.02M Dec/2025
Oriola-kd EUR 750.6M 14.8M Sep/2025
Owens Minor USD 947.08M 1.52B Dec/2025
Quest Diagnostics USD 2.28B 144M Dec/2025
Rede D'or Sao Luiz BRL 18.67B 280.37M Sep/2025
Siemens Healthineers EUR 13.65B 1.01B Dec/2025
Sonova Holding CHF 1.5B 303M Jun/2025
Supermax Corporation Bhd MYR 320.15M 22.1M Sep/2025
UnitedHealth USD 115.53B 4.74B Sep/2025
Veeva Systems USD 1.64B 692.18M Dec/2025
Veradigm USD 253.09M 3.24M Sep/2022
Xerox USD 3.4B 973M Sep/2025